Godavari Biorefineries Q2 Loss Narrows 63% as Revenue Rises

Godavari Biorefineries Limited reported a consolidated net loss of Rs 15.24 crore for Q2 FY27, 63.36% lower than the Rs 41.59 crore loss a year earlier, while revenue rose 27.51% year-on-year to Rs 549.24 crore. The September-quarter result matters because operating profit turned positive despite continued pressure from input costs and finance charges.

What did Godavari Biorefineries report for Q2 FY27?

Godavari Biorefineries reported consolidated revenue of Rs 549.24 crore for the quarter ended September 30, 2026, compared with Rs 430.75 crore in Q2 FY26. The company recorded a net loss of Rs 15.24 crore, against a loss of Rs 41.59 crore in the corresponding quarter of the previous year.

The supplied financial details also state revenue from operations of Rs 54,524.08 lakh, equivalent to Rs 545.24 crore, and total expenses of Rs 58,051.15 lakh, or Rs 580.51 crore. This differs from the Rs 549.24 crore revenue figure cited in the quarterly-results summary. The company filing cited in the source should remain the reference point for investors assessing the final line-item presentation.

Basic and diluted earnings per share were negative Rs 2.98 for Q2 FY27. No dividend was declared for the period. The board approved the unaudited standalone and consolidated results at its meeting on November 4, 2026, for the quarter and half year ended September 30, 2026.

Why did the quarterly loss narrow despite higher expenses?

Godavari Biorefineries narrowed its loss as revenue growth and an improvement in operating performance offset part of the increase in expenses. Total expenses rose to Rs 580.51 crore from Rs 485.95 crore in Q2 FY26, according to the figures provided, but the company still reported positive operating profit of Rs 10.33 crore against an operating loss of Rs 7.93 crore a year earlier.

The results summary attributed revenue growth to higher volumes in the sugar and bio-based chemicals businesses. It also stated that elevated input costs and finance charges kept the company at a net loss even after the operating-level improvement. This distinction is important because a positive operating result does not automatically translate into a net profit when financing and other costs remain significant.

EBITDA was reported at Rs 10.9 crore in Q2 FY27, compared with negative Rs 4.4 crore in Q2 FY26. The difference between this EBITDA figure and the stated operating-profit figure reflects that the supplied material uses more than one operating-performance measure, so investors will need to review the detailed filing and management discussion for definitions and reconciliations.

Which businesses supported Godavari Biorefineries in the quarter?

Godavari Biorefineries operates in sugar, cogeneration, bio-based chemicals and distillery businesses, with bio-based chemicals identified as the principal profit contributor in Q2 FY27. The segment reported operating profit of Rs 18.77 crore during the quarter, based on the information provided.

Management said bio-based chemicals revenue rose about 39% year-on-year and segment EBITDA increased roughly 47% year-on-year, helped by debottlenecking initiatives. These figures indicate that the chemicals operation contributed meaningfully to the improvement in the company's consolidated operating performance.

The sugar business continued to report operating losses, although the scale of that loss declined from earlier quarters. The company has also cautioned that some of its businesses are seasonal, meaning a single quarter may not be representative of full-year financial performance. That seasonality is relevant when comparing the September quarter with either earlier or later periods.

What should investors take from the Q2 FY27 results?

Godavari Biorefineries delivered stronger revenue and a substantially smaller loss, but it remained loss-making at the net level. For investors, the key reported change was the move to positive operating profit, alongside a 27.51% rise in revenue and a 63.36% reduction in the net loss.

The company scheduled an earnings conference call for November 6, 2026, at 11:00 AM IST to discuss Q2 and H1 FY27 performance. It said no unpublished price-sensitive information would be shared on the call. Management commentary on costs, finance charges, the sugar business and bio-based chemical capacity will provide further context to the reported quarterly figures.

The supplied material also refers to a licence agreement with Catalyxx Inc for exclusive Indian manufacturing rights for technology converting ethanol into biobutanol and higher alcohols. A first-phase plant has a stated annual capacity target of 15,000 metric tonnes and was targeted for commissioning in Q2 FY27. The source does not provide a commissioning update, financial contribution or revised timeline.

Conclusion

Godavari Biorefineries' Q2 FY27 result showed a clear improvement in operating performance, with revenue rising to Rs 549.24 crore, operating profit turning positive and the consolidated loss narrowing to Rs 15.24 crore. However, the continuing net loss and higher expenses show that profitability after finance and other costs remains unresolved.

Investors should watch management's November 6 earnings call for clarification on the revenue figure discrepancy in the supplied data, segment margins, input-cost trends and finance charges. Updates on the proposed 15,000-tonne biobutanol and higher-alcohol facility would also be relevant, as the supplied information gives a target but no confirmed operational status.